Hualan Biological Vaccine Inc. (SZSE: 301207)
Health Care · Biotechnology · CN
CN¥17.47
+2.28% today · -8.1% 1Y
Hualan Biological Vaccine Inc. (SZSE: 301207) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.55B and employs 708 people.
Over the last twelve months the share price has lost 8.1%, trading between 15.43 and 27.88.
Tweenvest scores Hualan Biological Vaccine Inc. across four factors: quality 70/100, value 30/100, growth 21/100, dividend 64/100. Its strongest factor is quality.
301207 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.55B
- Revenue (TTM)
- $174.70M
- P/E
- 55.44
- EPS
- 0.32
- Dividend yield
- 9.37%
- Beta (5Y)
- 0.60
- 52-week high
- CN¥27.88
- 52-week low
- CN¥15.43
- Avg volume (3M)
- —
- Shares outstanding
- 595.00M
- Employees
- 708
- Next earnings
- —
About Hualan Biological Vaccine Inc.
Hualan Biological Bacterin Inc. is a Chinese pharmaceutical company focused on the entire vaccine lifecycle, from research and development to manufacturing and sales within China. The company's product line features a diverse range of immunizations, including various influenza virus vaccines (such as split, quadrivalent, and H1N1 strains), recombinant hepatitis B vaccines, and meningococcal polysaccharide vaccines (including ACYW135 and Group A & C types). They also develop genetically engineered vaccines for human use. Established in 2005, Hualan Biological Bacterin Inc. is headquartered in Xinxiang, China, and previously operated as a subsidiary of Hualan Biological Engineering Inc.
- ISIN
- CNE1000058J9
- Founded
- 2005
- Listed since
- Feb 18, 2022
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $266.82 | +0.39% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $445.50 | +0.74% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.00 | -0.15% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.01 | -0.52% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.